Your browser doesn't support javascript.
loading
The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.
Pang, Yu-Yan; Li, Jian-Di; Gao, Li; Yang, Xia; Dang, Yi-Wu; Lai, Ze-Feng; Liu, Li-Min; Yang, Jie; Wu, Hua-Yu; He, Rong-Quan; Huang, Zhi-Guang; Xiong, Dan-Dan; Yang, Li-Hua; Shi, Lin; Mo, Wei-Jia; Tang, Deng; Lu, Hui-Ping; Chen, Gang.
Afiliação
  • Pang YY; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Li JD; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Gao L; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Yang X; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Dang YW; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Lai ZF; School of Pharmacy, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Liu LM; School of Pharmacy, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Yang J; School of Pharmacy, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Wu HY; Department of Cell Biology and Genetics, School of Pre-Clinical Medicine, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • He RQ; Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Huang ZG; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Xiong DD; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Yang LH; Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Shi L; Department of Pathology, Second Affiliated Hospital of Guangxi Medical University, Nanning, P.R. China.
  • Mo WJ; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Tang D; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Lu HP; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
  • Chen G; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.
Cancer Med ; 9(21): 8004-8019, 2020 11.
Article em En | MEDLINE | ID: mdl-32931665
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / Neoplasias Hepáticas / Monoaminoxidase Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Med Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / Neoplasias Hepáticas / Monoaminoxidase Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Med Ano de publicação: 2020 Tipo de documento: Article